- Home
- NCSM vs PEPG Comparison
NCSM vs PEPG Comparison
Compare NCSM & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- PEPG
- Stock Information
- Founded
- NCSM 2006
- PEPG 2018
- Country
- NCSM United States
- PEPG United States
- Employees
- NCSM N/A
- PEPG N/A
- Industry
- NCSM Oilfield Services/Equipment
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- NCSM Energy
- PEPG Health Care
- Exchange
- NCSM Nasdaq
- PEPG Nasdaq
- Market Cap
- NCSM 73.8M
- PEPG 64.2M
- IPO Year
- NCSM 2017
- PEPG 2022
- Fundamental
- Price
- NCSM $29.60
- PEPG $1.23
- Analyst Decision
- NCSM
- PEPG Buy
- Analyst Count
- NCSM 0
- PEPG 3
- Target Price
- NCSM N/A
- PEPG $14.67
- AVG Volume (30 Days)
- NCSM 7.1K
- PEPG 277.5K
- Earning Date
- NCSM 03-06-2025
- PEPG 03-05-2025
- Dividend Yield
- NCSM N/A
- PEPG N/A
- EPS Growth
- NCSM N/A
- PEPG N/A
- EPS
- NCSM 16.77
- PEPG N/A
- Revenue
- NCSM $152,801,000.00
- PEPG N/A
- Revenue This Year
- NCSM $13.26
- PEPG N/A
- Revenue Next Year
- NCSM $6.32
- PEPG N/A
- P/E Ratio
- NCSM $1.73
- PEPG N/A
- Revenue Growth
- NCSM 3.66
- PEPG N/A
- 52 Week Low
- NCSM $14.75
- PEPG $1.20
- 52 Week High
- NCSM $31.82
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- NCSM 54.01
- PEPG 15.20
- Support Level
- NCSM $27.60
- PEPG $1.77
- Resistance Level
- NCSM $31.82
- PEPG $2.03
- Average True Range (ATR)
- NCSM 1.05
- PEPG 0.24
- MACD
- NCSM -0.25
- PEPG -0.03
- Stochastic Oscillator
- NCSM 40.04
- PEPG 3.32
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.